139 related articles for article (PubMed ID: 19534678)
21. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Med Chem; 2008 Sep; 4(5):482-91. PubMed ID: 18782045
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of pyruvate-isoniazid analogs and their copper complexes as potential ICL inhibitors.
Shingnapurkar D; Dandawate P; Anson CE; Powell AK; Afrasiabi Z; Sinn E; Pandit S; Venkateswara Swamy K; Franzblau S; Padhye S
Bioorg Med Chem Lett; 2012 May; 22(9):3172-6. PubMed ID: 22475559
[TBL] [Abstract][Full Text] [Related]
25. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
26. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.
Banerjee D; Yogeeswari P; Bhat P; Thomas A; Srividya M; Sriram D
Eur J Med Chem; 2011 Jan; 46(1):106-21. PubMed ID: 21093117
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Wsól V; Vinšová J
Eur J Med Chem; 2012 Oct; 56():108-19. PubMed ID: 22960697
[TBL] [Abstract][Full Text] [Related]
28. Substituted N-phenylitaconamides as inhibitors of mycobacteria and mycobacterial isocitrate lyase.
Krátký M; Novotná E; Stolaříková J; Švarcová M; Vinšová J
Eur J Pharm Sci; 2022 Sep; 176():106252. PubMed ID: 35793749
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives.
Sriram D; Bal TR; Yogeeswari P; Radha DR; Nagaraja V
J Gen Appl Microbiol; 2006 Aug; 52(4):195-200. PubMed ID: 17116967
[TBL] [Abstract][Full Text] [Related]
30. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
31. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives.
Feng LS; Liu ML; Zhang S; Chai Y; Wang B; Zhang YB; Lv K; Guan Y; Guo HY; Xiao CL
Eur J Med Chem; 2011 Jan; 46(1):341-8. PubMed ID: 21146257
[TBL] [Abstract][Full Text] [Related]
35. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
Krátký M; Vinšová J
Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
[TBL] [Abstract][Full Text] [Related]
36. Isocitrate lyase: a potential target for anti-tubercular drugs.
Sharma R; Das O; Damle SG; Sharma AK
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018
[TBL] [Abstract][Full Text] [Related]
37. Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains.
Rijo P; Simões MF; Francisco AP; Rojas R; Gilman RH; Vaisberg AJ; Rodríguez B; Moiteiro C
Chem Biodivers; 2010 Apr; 7(4):922-32. PubMed ID: 20397225
[TBL] [Abstract][Full Text] [Related]
38. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
[TBL] [Abstract][Full Text] [Related]
39. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
[TBL] [Abstract][Full Text] [Related]
40. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]